Similar articles for PMID: 29848723

Year	Number of Results
1985	1
1988	1
1991	1
1996	2
1998	4
1999	2
2001	3
2002	3
2003	2
2004	3
2005	4
2006	5
2007	4
2008	3
2009	1
2010	3
2011	1
2012	1
2013	1
2015	1
2016	3
2017	3
2018	9
2019	6
2020	2
2021	5
2022	3
2023	0

1

Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.

Rades D, Bartscht T, Idel C, Schild SE, Hakim SG. Rades D, et al. Anticancer Res. 2018 Jun;38(6):3653-3656. doi: 10.21873/anticanres.12641. Anticancer Res. 2018. PMID: 29848723

2

Re-irradiation with 36 Gy (1.5 Gy Twice Daily) Plus Paclitaxel for Advanced Recurrent and Previously Irradiated SCCHN is Feasible.

Rades D, Bartscht T, Idel C, Hakim SG. Rades D, et al. Anticancer Res. 2018 Jan;38(1):519-523. doi: 10.21873/anticanres.12253. Anticancer Res. 2018. PMID: 29277818

3

Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.

Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J. Kuhnt T, et al. Strahlenther Onkol. 2003 Oct;179(10):673-81. doi: 10.1007/s00066-003-1106-0. Strahlenther Onkol. 2003. PMID: 14566475 Clinical Trial.

4

Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck.

Rades D, Seidl D, Wollenberg B, Schild SE, Hakim SG. Rades D, et al. Anticancer Res. 2016 Oct;36(10):5463-5468. doi: 10.21873/anticanres.11126. Anticancer Res. 2016. PMID: 27798916

5

Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.

Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA. Langer CJ, et al. Cancer Invest. 2006 Mar;24(2):164-73. doi: 10.1080/07357900500524421. Cancer Invest. 2006. PMID: 16537186 Clinical Trial.

6

Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck.

Feher O, Martins SJ, Lima CA, Salvajoli JV, Simpson AJ, Kowalski LP. Feher O, et al. Head Neck. 2002 Mar;24(3):228-35. doi: 10.1002/hed.10049. Head Neck. 2002. PMID: 11891954 Clinical Trial.

7

[Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].

Chen CY, Lu TX, Zhao C, Lu LX, Han F, Sun Y. Chen CY, et al. Ai Zheng. 2007 Apr;26(4):398-402. Ai Zheng. 2007. PMID: 17430660 Free article. Clinical Trial. Chinese.

8

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.

Kies MS, Haraf DJ, Rosen F, Stenson K, List M, Brockstein B, Chung T, Mittal BB, Pelzer H, Portugal L, Rademaker A, Weichselbaum R, Vokes EE. Kies MS, et al. J Clin Oncol. 2001 Apr 1;19(7):1961-9. doi: 10.1200/JCO.2001.19.7.1961. J Clin Oncol. 2001. PMID: 11283128 Clinical Trial.

9

Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.

Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Kramer NM, et al. Head Neck. 2005 May;27(5):406-14. doi: 10.1002/hed.20163. Head Neck. 2005. PMID: 15719391 Clinical Trial.

10

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.

Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF. Amrein PC, et al. Cancer. 2005 Oct 1;104(7):1418-27. doi: 10.1002/cncr.21312. Cancer. 2005. PMID: 16116597 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed